Compositions and methods for diagnosing and treating mental disorders

Details for Australian Patent Application No. 2004289247 (hide)

Owner The Board of Trustees of The Leland Stanford Junior University

Inventors Bunney Jr., William E.; Thompson, Robert C.; Li, Jun; Jones, Edward G.; Atz, Mary; Tomita, Hiroaki; Lopez, Juan F.; Evans, Simon J.; Akil, Huda; Vawter, Marquis P.; Myers, Richard; Watson, Stanley; Choudary, Prabhakara V.

Agent Pizzeys

Pub. Number AU-A-2004289247

PCT Pub. Number WO2005/046434

Priority 10/982,556 04.11.04 US; 60/517,751 05.11.03 US

Filing date 5 November 2004

Wipo publication date 26 May 2005

International Classifications

A61K 31/519 (2006.01) - ortho- or peri-condensed with heterocyclic rings

A61K 48/00 (2006.01) Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases

C12Q 1/68 (2006.01) Measuring or testing processes involving enzymes or micro-organisms - involving nucleic acids

Event Publications

11 May 2006 PCT application entered the National Phase

  PCT publication WO2005/046434 Priority application(s): WO2005/046434

20 January 2011 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(e). Examination has been requested or an examination report has issued for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2004289248-Tobacco compositions

2004289243-4-anilino-3-quinolinecarbonitriles for the treatment of chronic myelogenous leukemia (CML)